| Literature DB >> 16674948 |
Annemarie Wehenkel1, Pablo Fernandez, Marco Bellinzoni, Vincent Catherinot, Nathalie Barilone, Gilles Labesse, Mary Jackson, Pedro M Alzari.
Abstract
Mycobacterium tuberculosis PknB is an essential receptor-like protein kinase involved in cell growth control. Here, we demonstrate that mitoxantrone, an anthraquinone derivative used in cancer therapy, is a PknB inhibitor capable of preventing mycobacterial growth. The structure of the complex reveals that mitoxantrone partially occupies the adenine-binding pocket in PknB, providing a framework for the design of compounds with potential therapeutic applications. PknB crystallizes as a 'back-to-back' homodimer identical to those observed in other structures of PknB in complex with ATP analogs. This organization resembles that of the RNA-dependent protein kinase PKR, suggesting a mechanism for kinase activation in mycobacteria.Entities:
Mesh:
Substances:
Year: 2006 PMID: 16674948 DOI: 10.1016/j.febslet.2006.04.046
Source DB: PubMed Journal: FEBS Lett ISSN: 0014-5793 Impact factor: 4.124